Annual Dermatology Drug Development Summit

The Annual Dermatology Drug Development Summit is the industry's premier destination for discovering and developing best-in-class drugs for immuno-inflammatory skin diseases. This event is dedicated to addressing the complexities and challenges within dermatology, focusing on disease heterogeneity to uncover novel therapeutic targets and ensuring a commercially viable clinical strategy for bringing innovative treatments to market. Participants will engage in insightful discussions that tackle the pressing R&D bottlenecks in dermatology, emphasizing the importance of safety and efficacy in novel therapeutics.As the field experiences significant clinical and commercial momentum, the summit features industry leaders who will share their expertise on various topics including groundbreaking clinical trial findings across both rare and common skin diseases such as atopic dermatitis (AD), psoriasis, hidradenitis suppurativa (HS), vitiligo, pemphigus nodularis, bullous pemphigoid, and alopecia areata. Attendees will explore the latest advancements in drug modalities, from bispecific antibodies to oligonucleotides, and hear from influential figures in the medical community, including Shawn Seong, who serves as the Chief Executive Officer and Senior Director of Global Medical Immunology. The program fosters a collaborative environment for in-depth, scientifically grounded discussions on the evolving treatment landscape for inflammatory skin diseases, addressing key development challenges related to immune modulation, barrier dysfunction, and chronic inflammation.In addition to the main summit, participants will have opportunities to network and engage in interactive roundtables and panel discussions, connecting with peers from across the biopharma sector to share insights and forge valuable relationships. The event is designed for a diverse audience, including professionals involved in discovery, preclinical, translational, clinical, and medical affairs, ensuring that all aspects of dermatology drug development are covered. This summit not only aims to accelerate the development of differentiated drugs but also to highlight the potential of microbiome research in new indications. Attendees are encouraged to position themselves alongside leading solution providers, making it a prime opportunity for career advancement and impactful contributions within the field of dermatology.